Arbutus Biopharma
(NASDAQ) ABUS
Arbutus Biopharma Financials at a Glance
Market Cap
$900.77M
Revenue (TTM)
$191.45M
Net Income (TTM)
$160.72M
EPS (TTM)
$0.82
P/E Ratio
5.54
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Price
$4.56
Volume
2,383,772
Open
$4.61
Price
$4.56
Volume
2,383,772
Open
$4.61
Previous Close
$4.56
Daily Range
$4.53 - $4.70
52-Week Range
$3.04 - $5.10
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Price
$4.56
Volume
2,383,772
Open
$4.61
Previous Close
$4.56
Daily Range
$4.53 - $4.70
52-Week Range
$3.04 - $5.10
ABUS News
ABUS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Arbutus Biopharma
Industry
Biotechnology
Sector
Health CareEmployees
19
CEO
Lindsay Androski, CFA, MBA
Website
www.arbutusbio.comHeadquarters
Warminster, PA 18974, US
ABUS Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
81%
Net Income Margin
84%
Return on Equity
95%
Return on Capital
57%
Return on Assets
58%
Earnings Yield
18.05%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$900.77M
Shares Outstanding
197.54M
Volume
2.38M
Avg. Volume
2.20M
Financials (TTM)
Gross Profit
$13.72M
Operating Income
-$27.05M
EBITDA
-$26.69M
Operating Cash Flow
-$39.64M
Capital Expenditure
$0.00
Free Cash Flow
-$39.64M
Cash & ST Invst.
$91.47M
Total Debt
$4.19M
Arbutus Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$179.13M
+10054.5%
Gross Profit
$179.12M
+2589.4%
Gross Margin
99.99%
N/A
Market Cap
$900.77M
N/A
Market Cap/Employee
$20.47M
N/A
Employees
44
N/A
Net Income
$169.70M
+791.9%
EBITDA
$169.13M
+799.9%
Quarterly Fundamentals
Net Cash
$94.60M
-15.2%
Accounts Receivable
$1.31M
+11.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$631.00K
+12.1%
Return on Assets
57.99%
N/A
Return on Invested Capital
56.85%
N/A
Free Cash Flow
-$8.11M
+39.4%
Operating Cash Flow
-$8.11M
+39.4%